influenzalik
ill
ili
acut
respiratori
infect
ari
children
common
clinic
present
may
rang
subtl
sever
symptom
requir
advanc
medic
care
wide
spectrum
diseas
present
role
risk
factor
rf
term
diseas
sever
poorli
understood
laboratori
diagnost
usual
order
routin
care
surveil
program
reli
laboratoryconfirm
case
rather
clinic
suspicion
solv
denomin
problem
allow
time
detect
virusspecif
season
given
sub
popul
even
greater
challeng
present
investig
wish
determin
impact
differ
respiratori
virus
diseas
burden
deeper
understand
diseas
sever
relat
specif
respiratori
virus
help
monitor
realworld
impact
natur
untreat
diseas
well
prevent
measur
therapeut
intervent
vaccin
antivir
time
detect
season
help
target
costeffect
use
viral
diagnost
hospitalbas
surveil
set
ideal
viral
diagnost
align
simultan
standard
diseas
sever
assess
standard
measur
diseas
sever
urgent
need
clinic
trial
vaccin
antivir
current
develop
ari
caus
influenza
flu
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
adenoviru
adv
human
rhinoviru
hrv
furthermor
would
desir
assess
point
care
patient
suffer
sever
diseas
relat
perceiv
rf
profil
use
pointofcar
assess
individu
use
antiinfect
therapi
experi
recent
influenza
pandem
shown
influenza
diseas
sever
appear
rather
unpredict
especi
young
patient
whilst
major
adult
sever
diseas
previous
identifi
rf
major
children
affect
sever
diseas
expect
perceiv
risk
sever
outcom
may
also
influenc
physician
decis
test
patient
influenza
respiratori
virus
littl
consensu
symptom
trigger
physician
suspicion
local
practic
differ
significantli
site
site
season
season
comprehens
review
publish
literatur
diseas
sever
measur
use
clinic
trial
surveil
system
lack
numer
observ
studi
clinic
trial
assess
prevent
treatment
influenza
respiratori
virus
rather
inconsist
commonli
use
indic
diseas
sever
hospit
diagnosi
pneumonia
advers
outcom
includ
mortal
known
highli
depend
studi
popul
medic
set
choic
data
sourc
avail
resourc
headtohead
comparison
metaanalys
compar
differ
prevent
treatment
intervent
requir
univers
accept
diseas
sever
measur
sentinel
surveil
system
tend
focu
privat
practic
laboratori
test
base
clinic
suspicion
behalf
primari
care
provid
work
surveil
site
children
promin
transmitt
influenza
pediatr
emerg
room
larg
tertiari
care
hospit
ideal
site
monitor
season
cover
entir
spectrum
clinic
present
creat
model
system
free
select
bia
perenni
qualiti
manag
qm
program
institut
larg
pediatr
academ
center
collabor
nation
refer
centr
influenza
respiratori
virus
specif
aim
present
analys
develop
standard
approach
measur
ili
diseas
sever
base
literatur
review
guidelin
andto
appli
new
mathemat
model
realtim
surveil
ili
larg
tertiari
care
center
understand
diseas
sever
paramet
use
clinic
trial
observ
studi
systemat
literatur
search
pubm
databas
perform
use
follow
search
term
diseas
sever
titleabstract
ill
sever
titleabstract
influenza
titleabstract
rhinovirus
titleabstract
adenoviru
titleabstract
human
metapneumoviru
titleabstract
respiratori
syncyti
viru
titleabstract
coronaviru
titleabstract
bocaviru
titleabstract
parainfluenza
viru
titleabstract
respiratori
viru
titleabstract
purpos
expert
review
literatur
review
updat
cover
public
date
januari
june
search
limit
human
studi
publish
english
abstract
screen
manual
exclud
accord
follow
criteria
studi
pediatr
studi
subject
major
year
old
studi
one
follow
random
clinic
trial
nonrandom
clinic
trial
observ
studi
epidemiolog
studi
studi
lack
clinic
criterion
diseas
sever
anim
studi
adult
studi
metaanalysi
review
paper
also
exclud
base
systemat
literatur
review
vivi
diseas
sever
score
develop
weigh
clinic
composit
score
accord
whocriteria
uncompl
complic
diseas
vivi
diseas
sever
score
compris
item
describ
sign
symptom
uncompl
diseas
diseas
sever
uncompl
dsu
weigh
singlefold
reflect
regular
ili
activ
wherea
item
describ
paramet
consist
complic
diseas
diseas
sever
complic
dsc
weigh
threefold
indic
highimpact
clinic
present
target
popul
textbox
vivi
diseas
sever
score
subsequ
user
test
interfac
well
mobil
applic
tablet
comput
use
point
care
base
commonli
cite
rf
sever
diseas
pediatr
adolesc
age
group
simpl
rf
score
compos
vivi
risk
factor
score
textbox
implement
mobil
applic
allow
report
diseas
sever
relat
previous
identifi
rf
individu
patient
consult
index
epidemiolog
indic
report
weekli
nation
refer
centr
influenza
respiratori
virus
influenza
work
group
base
proport
ari
repres
sentinel
practic
across
countri
consult
index
repres
time
indic
deviat
baselin
rate
ari
case
present
respect
sentinel
practic
normal
ari
activ
assum
consult
index
remain
increas
activ
typic
measur
winter
month
season
virus
circul
commun
fluctuat
ari
activ
measur
consult
index
repres
use
indic
diseas
burden
base
actual
case
number
report
number
case
howev
reveal
inform
diseas
sever
individu
case
plot
consult
index
correspond
averag
vivi
diseas
sever
score
graph
obtain
comprehens
pictur
ari
diseas
burden
base
actual
case
number
case
sever
figur
illustr
diseas
sever
alway
follow
peak
trough
case
number
measur
use
consult
index
vivi
score
consult
index
therefor
measur
oppos
end
point
one
base
individu
diseas
sever
per
patient
vivi
diseas
sever
score
serv
epidemiolog
indic
ari
activ
overal
diseas
burden
within
nation
surveil
system
consult
index
vivi
diseas
sever
risk
factor
score
user
test
context
qm
program
children
ili
larg
pediatr
hospit
germani
describ
previous
accord
standard
oper
procedur
patient
physician
diagnosi
ili
andor
fulfil
predefin
case
criteria
bodi
temperatur
respiratori
symptom
admit
emerg
depart
ed
pediatr
inpati
ward
particip
qm
program
independ
routin
clinic
care
specif
train
qm
team
obtain
nasopharyng
sampl
perform
standard
clinic
assess
use
vivi
diseas
sever
score
line
criteria
uncompl
complic
influenza
vivi
diseas
sever
score
record
first
consult
patient
particip
qm
program
physician
routin
care
blind
result
clinic
assess
qm
staff
unawar
vivi
diseas
sever
score
assign
qm
team
qm
staff
hand
assess
patient
prior
alloc
treatment
decis
behalf
clinic
team
routin
care
nasopharyng
specimen
deliv
nation
refer
centr
influenza
respiratori
virus
individu
rtpcr
test
influenza
viru
b
rsv
hmpv
hrv
adv
describ
decemb
april
total
children
age
year
particip
qm
program
qm
program
includ
outpati
repres
broadest
possibl
spectrum
diseas
sever
patient
present
ed
screen
ili
criteria
weekli
regardless
whether
subsequ
admit
hospit
onward
daili
screen
inpati
ad
includ
weekend
holiday
qm
team
perform
diseas
sever
assess
independ
result
remain
unknown
routin
staff
henc
data
acquir
qm
team
influenc
treatment
hospit
decis
also
treat
physician
know
result
rtpcr
test
decid
neuraminidas
inhibitor
treatment
patient
laboratoryconfirm
influenza
infect
invit
particip
followup
assess
whenev
feasibl
followup
visit
qm
program
voluntari
schedul
accord
parent
prefer
followup
visit
vivi
diseas
sever
score
assess
repeat
record
qm
team
use
procedur
initi
assess
nasopharyng
sampl
repeat
sent
analog
rtpcr
test
qm
program
approv
institut
review
board
ea
inform
consent
procedur
waiv
enhanc
qualiti
care
infect
control
nasopharyng
swab
wash
total
volum
ml
cell
cultur
medium
either
individu
pool
per
patient
rna
extract
patient
specimen
use
magattract
viral
rna
kit
qiagen
hilden
germani
elut
elut
buffer
altern
rna
extract
use
magna
pure
dna
viral
na
small
volum
kit
roch
deutschland
hold
gmbh
mannheim
germani
specimen
elut
volum
volum
extract
rna
subject
cdna
synthesi
appli
u
mmlv
revers
transcriptas
invitrogen
karlsruh
germani
total
volum
cdna
sampl
analyz
rtpcr
presenc
pathogen
influenza
viru
b
rsv
hmpv
hrv
adv
publish
previous
descript
analysi
studi
sampl
perform
calcul
proport
summar
continu
variabl
use
mean
standard
deviat
rang
median
interquartil
rang
histogram
box
plot
use
illustr
distribut
vivi
diseas
sever
score
correl
vivi
diseas
sever
score
consult
index
assess
use
scatter
plot
pearson
correl
coeffici
mean
differ
vivi
diseas
sever
score
compar
across
patient
clinic
characterist
statist
signific
assess
use
ttest
chisquar
test
appropri
test
whether
patient
elev
vivi
diseas
sever
score
also
elev
rf
score
perform
correl
analysi
use
pearson
correl
coeffici
analys
conduct
use
stata
version
statacorp
lp
texa
usa
perform
regress
analys
identifi
set
influenti
rf
could
model
linear
correl
vivi
diseas
sever
score
rf
rf
wn
rf
n
wi
respect
weight
factor
featur
regress
model
subset
patient
laboratoryconfirm
influenza
infect
winter
season
vivi
diseas
sever
score
also
use
follow
patient
longitudin
respect
viral
load
diseas
sever
time
assess
relationship
vivi
diseas
sever
score
viru
load
perform
pearson
correl
analys
record
two
followup
time
point
virolog
vivi
diseas
sever
score
avail
decis
tree
analysi
perform
studi
relationship
subgroup
strong
posit
neg
correl
diseas
sever
viru
load
object
datadriven
measur
detect
season
respiratori
viral
infect
acut
care
set
introduc
time
seri
analysi
chang
point
cp
detect
goal
cp
detect
algorithm
identifi
chang
dynam
behavior
within
time
seri
main
differ
statist
orient
analysi
assum
intrins
dynam
model
gener
data
cp
detect
therefor
identifi
time
point
time
seri
trend
start
differ
significantli
previou
data
procedur
allow
identif
critic
time
point
weekli
averag
number
laboratoryconfirm
influenza
infect
start
increas
decreas
compar
preced
week
detail
cp
detect
pleas
refer
supplement
data
paper
use
cp
detect
approach
analyz
qm
dataset
allow
comput
averag
target
variabl
assign
respect
calendar
week
averag
rate
laboratoryconfirm
influenza
infect
per
calendar
week
averag
diseas
sever
per
calendar
week
etc
detect
season
pattern
use
follow
threestep
algorithm
data
cluster
use
kmean
cluster
potenti
season
use
k
model
two
main
season
high
low
transit
season
assign
preliminari
cp
week
wt
cluster
assign
c
wt
respect
week
differ
cluster
assign
preced
week
ie
c
wt
c
final
comput
list
preliminari
cp
would
split
dataset
time
frame
time
frame
ti
defin
lie
two
consecut
cp
check
preliminari
cp
whether
valu
cp
two
time
frame
differ
significantli
p
base
ttest
procedur
ensur
two
region
separ
cp
inde
differ
preliminari
cp
fulfil
criteria
report
systemat
literatur
search
yield
potenti
relev
articl
among
articl
exclud
base
criteria
mention
addit
studi
lack
specif
criteria
diseas
sever
final
total
number
elig
articl
identifi
characterist
summar
textbox
becam
evid
sever
clinic
paramet
share
multipl
studi
exampl
hospit
oxygen
requir
labor
breath
p
icu
admiss
mortal
feed
problemsdehydrationvomit
fever
wheez
abnorm
breath
sound
etc
commonli
use
criteria
includ
vivi
diseas
sever
score
see
also
tief
et
al
textbox
except
mortal
usual
record
separ
hospit
record
vivi
diseas
sever
score
valid
full
qm
cohort
compris
patient
age
year
mean
year
sd
rang
year
percentag
qm
program
particip
age
year
age
year
age
group
year
age
year
total
particip
male
total
particip
prescrib
antibiot
prescrib
antivir
hospit
present
assess
need
hospit
need
intens
care
includ
assist
ventil
extracorpor
membran
oxygen
regard
viral
etiolog
decreas
order
frequenc
identifi
rhinoviru
rsv
adv
influenza
viru
metapneumoviru
influenza
viru
influenza
b
virus
victorialineag
influenza
type
b
virus
yamagatalineag
case
concurr
viral
infect
tabl
summar
find
rf
assess
exercis
carri
part
qualiti
monitor
tabl
summar
clinic
symptom
present
total
patient
chestradiographi
ed
chest
radiographi
find
show
pneumonia
bronchiti
bronchiectasi
bronchiol
nonpneumonia
abnorm
one
hundr
nineteen
lumbar
punctur
done
ed
cerebrospin
fluid
csf
chemistri
done
sixtynin
csf
cultur
done
four
sampl
posit
bacteria
bacillu
speci
staphylococcu
epidermidi
staphylococcu
homini
unspecifi
bacteria
posit
case
streptococcu
pneumonia
identifi
cultur
hospit
lumbar
punctur
csf
chemistri
cultur
done
four
sampl
posit
bacteria
includ
escherichia
coli
micrococcu
staphyococcu
epidermidi
streptococcu
salivariu
streptococcu
mitisorali
well
enteroviru
two
case
case
streptococcu
pneumonia
identifi
cultur
total
chest
radiograph
inpati
stay
inpati
chest
radiographi
find
show
pneumonia
bronchiti
bronchiol
bronchiectasi
nonpneumonia
abnorm
total
studi
particip
diagnos
pneumonia
chest
radiographi
point
hospit
two
death
record
emerg
room
one
death
attribut
enceph
sepsi
follow
infect
caus
death
second
patient
relat
seriou
underli
cardiac
diseas
young
infant
vivi
diseas
sever
score
show
normal
distribut
mean
score
sd
rang
initi
assess
figur
vivi
diseas
sever
score
significantli
higher
patient
need
hospit
mean
differ
ci
p
need
critic
care
facil
mean
differ
ci
p
well
sign
primari
secondari
bacteri
lower
respiratori
tract
infect
mean
differ
ci
p
median
risk
factor
score
cohort
iqr
median
rf
score
sd
score
rang
cp
analysi
appli
detect
season
pattern
viru
detect
qm
cohort
defin
viru
season
present
whole
year
definit
found
influenza
virus
figur
well
rsv
hmpv
show
strong
season
behavior
figur
predomin
northern
hemispher
winter
month
adv
hrv
rapid
cycler
frequent
brief
peak
throughout
year
figur
cp
method
show
hospitalbas
syndrom
surveil
system
season
detect
defin
real
time
respiratori
virus
postpandem
season
exampl
influenza
virus
continu
predomin
qm
cohort
influenza
virus
hand
absent
season
replac
pandem
strain
subsequ
season
see
figur
also
differenti
influenza
b
lineag
reveal
influenza
b
yamagata
victoria
virus
alway
circul
annual
instead
show
altern
pattern
cp
analysi
also
use
identifi
fluctuat
averag
diseas
sever
per
calendar
week
qm
program
figur
initi
period
summer
qm
program
restrict
onceweekli
screen
outpati
ed
visual
separ
full
surveil
phase
begin
winter
season
daili
screen
inpati
hospit
suspect
ili
ad
use
vivi
diseas
sever
score
perenni
hospitalbas
surveil
provid
standard
diseas
sever
report
throughout
cours
year
small
signific
differ
vivi
diseas
sever
score
subject
viral
etiolog
could
detect
mean
vivi
diseas
sever
score
sd
identifi
singl
viral
infect
mean
vivi
diseas
sever
score
sd
concurr
viral
infect
mean
vivi
diseas
sever
score
sd
p
anova
patient
qm
cohort
comput
overal
vivi
diseas
sever
score
well
compon
dsu
dsc
symptom
categori
respect
tabl
averag
diseas
sever
differ
respiratori
viral
infect
reveal
rsv
induc
highest
level
diseas
sever
follow
hmpv
influenza
hrv
infect
diseas
sever
adv
influenza
b
influenza
virus
remain
averag
tabl
vivi
diseas
sever
score
distribut
includ
viral
coinfect
display
figur
illustr
comparison
comput
averag
vivi
diseas
sever
score
per
calendar
week
compar
consult
index
week
figur
expect
signific
correl
observ
weekli
vivi
diseas
sever
score
consult
index
pearson
correl
coeffici
r
p
correspond
week
indic
diseas
sever
case
number
link
allow
visual
interpret
also
plot
weekli
averag
vivi
diseas
sever
score
ed
prior
octob
ed
inpati
unit
thereaft
time
cours
respect
season
virus
result
shown
figur
b
virus
circul
repres
qm
patient
test
axi
shown
relationship
averag
vivi
diseas
sever
score
respect
calendar
week
virus
peak
simultan
averag
diseas
sever
cumul
effect
common
effect
virus
preval
summer
month
pronounc
inpati
includ
qm
program
thu
includ
sever
case
requir
hospit
admiss
pearson
correl
coeffici
r
indic
statist
signific
weak
posit
correl
vivi
diseas
sever
risk
factor
score
p
distribut
vivi
diseas
sever
score
differ
rf
illustr
tabl
evalu
rf
defin
textbox
highest
impact
diseas
sever
ie
vivi
diseas
sever
score
perform
regress
analysi
follow
vivi
diseas
sever
score
rf
rf
wn
rf
n
regress
analysi
reveal
specif
set
variabl
could
use
model
relationship
significantli
well
best
subset
rf
variabl
rf
infant
year
age
rf
cardiac
condit
rf
pulmonari
condit
rf
obes
rf
diabet
togeth
yield
goodnessoffit
use
rf
variabl
yield
explor
relationship
age
rf
studi
median
mean
vivi
diseas
sever
score
infant
children
year
age
children
age
year
tabl
perform
pearson
correl
test
potenti
relationship
vivi
diseas
sever
score
patient
age
pearson
collat
reveal
r
suggest
fact
signific
correl
vivi
diseas
sever
score
patient
age
increas
vivi
diseas
sever
score
indic
increas
diseas
sever
key
aspect
vivi
diseas
sever
score
provid
data
standard
across
full
spectrum
sever
well
comparison
within
cohort
differ
season
site
futur
may
allow
comparison
variou
treatment
decis
clinic
trial
observ
set
describ
physician
routin
care
unawar
result
vivi
diseas
sever
score
assess
qm
staff
revers
qm
staff
unawar
treatment
decis
assess
patient
analysi
vivi
diseas
sever
score
result
reveal
diseas
sever
patient
viru
prescrib
neuraminidas
inhibitor
ci
compar
ci
individu
prescrib
neuraminidas
inhibitor
time
present
ed
mean
differ
ci
p
patient
pcrconfirm
influenza
infect
differ
upheld
mean
vivi
diseas
sever
score
patient
physician
decid
prescrib
neuraminidas
inhibitor
ci
compar
ci
patient
without
antivir
therapi
mean
differ
ci
p
similarli
patient
prescrib
antibiot
routin
care
also
show
higher
vivi
diseas
sever
score
ci
compar
mean
score
ci
individu
without
antibiot
prescript
mean
differ
ci
p
consid
variabl
diseas
present
cours
ill
influenza
respiratori
viral
infect
children
vivi
diseas
sever
score
intend
valid
futur
clinic
event
outcom
assess
whether
vivi
diseas
sever
score
could
use
standard
consecut
followup
visit
clinic
trial
total
number
qm
patient
influenza
diagnos
follow
longitudin
virolog
pcr
diseas
sever
assess
time
overal
pearson
correl
vivi
diseas
sever
score
viru
load
use
cycl
threshold
ct
valu
time
closer
look
correl
histogram
figur
reveal
three
major
subgroup
largest
group
patient
categor
moder
strong
posit
correl
r
diseas
sever
viral
load
time
second
group
patient
show
strong
neg
correl
r
third
group
patient
show
weak
posit
neg
correl
r
preliminari
decis
tree
analysi
group
suggest
vivi
diseas
sever
score
rf
infant
year
age
connect
neg
correl
viru
load
diseas
sever
respiratori
infect
among
common
reason
children
admit
pediatr
hospit
hospitalbas
surveil
respiratori
viral
infect
great
valu
understand
full
diseas
spectrum
mild
symptom
seriou
present
children
avid
transmitt
respiratori
viral
infect
inform
gain
syndrom
surveil
children
hospit
complement
decentr
sentinel
surveil
system
meaning
way
advent
rapid
diagnost
mobil
health
applic
becom
possibl
monitor
virolog
clinic
end
point
real
time
tradit
diseas
activ
monitor
base
epidemiolog
paramet
ili
ari
incid
hospit
rate
mortal
consult
index
develop
robert
koch
institut
proven
sophist
epidemiolog
tool
assess
background
ari
activ
repres
sentinel
practic
fluctuat
ari
activ
privat
practic
repres
use
indic
diseas
burden
base
actual
case
number
report
number
case
howev
reveal
inform
diseas
sever
individu
case
vivi
diseas
sever
score
aim
fill
gap
vivi
diseas
sever
score
weigh
clinic
composit
score
consist
dsu
item
reflect
regular
ili
activ
dsc
item
indic
highimpact
clinic
present
target
popul
vivi
diseas
sever
score
open
avenu
new
individu
patient
data
ipd
analys
exampl
identifi
clinic
relev
season
pattern
diseas
sever
link
differ
viral
diagnos
confirm
group
patient
vivi
diseas
sever
score
also
allow
consist
measur
diseas
sever
follow
individu
patient
time
would
case
clinic
trial
followup
assess
use
whenev
standard
sever
data
need
recaptur
time
frequent
snap
shot
diseas
sever
combin
virolog
data
may
possibl
gener
move
imag
interest
new
applic
clinic
research
introduct
standard
diseas
sever
score
facilit
headtohead
comparison
metaanalyz
clinic
trial
observ
studi
full
complianc
vivi
diseas
sever
score
mobil
applic
clinic
data
interchang
standard
consortium
cdisc
standard
expand
data
interoper
complianc
report
format
regulatori
agenc
import
note
scope
propos
diseas
sever
measur
expert
review
intend
rais
expect
diseas
sever
score
could
use
predict
futur
event
physician
behavior
instead
introduc
simpl
weight
clinic
composit
score
allow
assessor
translat
current
condit
patient
twodigit
number
allow
comparison
one
patient
anoth
regardless
set
end
paper
provid
descript
account
standard
score
util
assess
relationship
observ
score
variou
independ
treatment
manag
decis
reader
draw
conclus
may
turn
use
vivi
diseas
sever
score
clinic
practic
research
expert
review
also
introduc
time
seri
analysi
chang
point
detect
mathemat
model
appli
first
time
determin
time
season
respiratori
virus
circul
hospit
ad
emerg
room
observ
sever
virus
may
circul
season
pattern
new
author
demonstr
pure
datainher
definit
season
could
interest
addit
tradit
use
method
comparison
averag
vivi
diseas
sever
score
hospit
system
consult
index
calendar
week
ie
simultan
ari
consult
sentinel
practic
reveal
two
paramet
intrins
differ
heavi
season
high
frequenc
ari
consult
light
season
fewer
sever
case
individu
assess
qm
cohort
detect
fluctuat
diseas
sever
time
increas
overal
ari
incid
gener
popul
evid
especi
atyp
influenza
season
unusu
unusu
sever
case
monitor
diseas
sever
addit
incid
rate
provid
import
complementari
inform
standard
diseas
sever
assess
also
enabl
crosscohort
comparison
diseas
burden
differ
viral
pathogen
surpris
rsv
identifi
key
contributor
diseas
sever
tertiari
children
hospit
follow
hmpv
diseas
better
understand
realworld
impact
differ
respiratori
virus
child
health
help
priorit
drug
vaccin
develop
develop
vivi
diseas
sever
score
base
systemat
review
publish
literatur
review
show
sever
assess
inconsist
four
clinic
manag
paramet
use
commonli
indic
diseas
sever
hospit
intens
care
treatment
oxygen
supplement
mechan
ventil
invas
noninvas
avail
measur
howev
highli
depend
set
vivi
diseas
sever
score
therefor
use
need
hospit
need
icu
admiss
determin
assessor
instead
assessor
determin
patient
would
benefit
measur
item
score
regardless
avail
icu
hospit
bed
respect
time
locat
ensur
interrat
consist
qm
team
specif
train
appli
establish
definit
standard
criteria
assess
aspect
vivi
diseas
sever
score
exampl
fever
defin
accord
marci
et
al
acut
lower
respiratori
tract
infect
per
roth
et
al
use
multicent
set
vivi
diseas
sever
score
app
includ
help
menu
user
interfac
ensur
assessor
awar
criteria
ageappropri
valu
acknowledg
content
structur
qualiti
standard
data
paramount
import
develop
team
work
close
cdisc
ensur
full
complianc
terminolog
data
element
industri
regulatori
guidanc
literatur
review
show
grade
sever
predict
sever
especi
young
children
diseas
sever
fluctuat
time
episod
resolv
eventu
cours
ill
may
may
linear
vivi
diseas
sever
score
design
help
physician
measur
monitor
situat
ad
hoc
repeatedli
time
predict
futur
patient
sever
score
design
measur
sever
ad
hoc
predict
likelihood
fatal
outcom
futur
case
respiratori
index
sever
children
pediatr
index
mortal
score
pim
pediatr
risk
mortal
score
prim
latter
two
score
pim
prim
specif
rsv
infect
infant
kristjansson
clinic
respiratori
score
rsv
infect
children
design
includ
children
beyond
infant
age
group
index
sever
studi
bocaviru
infect
infant
children
year
symptom
score
coronaviru
infect
children
score
develop
measur
diseas
sever
regardless
type
respiratori
viru
caus
diseas
clinic
sever
score
use
monitor
rsv
hrv
hmpv
infect
children
year
systemat
literatur
review
updat
confirm
vivi
diseas
sever
score
score
cover
pediatr
age
group
respiratori
viru
encompass
key
paramet
outlin
publish
literatur
date
vivi
diseas
sever
score
also
composit
score
valid
prospect
cohort
children
adolesc
year
yield
normal
distribut
regular
sever
assess
time
combin
cp
detect
methodolog
detect
signific
chang
diseas
sever
cohort
hospit
surveil
thu
becom
feasibl
real
time
rapidturnaround
diagnost
test
evolv
use
rapid
diagnost
test
target
accord
local
surveil
inform
bioinformat
analys
machin
learn
algorithm
may
provid
new
avenu
identif
virusspecif
season
pattern
past
influenza
season
differ
composit
subtyp
diseas
sever
signific
linkag
simultan
viru
surveil
pointofcar
diseas
sever
assess
advanc
understand
local
epidemiolog
local
epidemiolog
key
understand
impact
differ
strain
differ
popul
north
america
influenza
virus
reappear
year
sooner
europ
ie
follow
unusu
light
season
late
case
winter
public
health
agenc
uk
report
particularli
sever
season
wherea
australia
report
increas
rate
sever
influenza
diseas
similar
mexico
classic
season
regard
sever
coincid
high
overal
case
number
hospit
rate
mortal
futur
import
distinguish
impact
fluctuat
influenza
sub
type
diseas
sever
specif
patient
group
base
ipd
use
standard
measur
sever
may
also
help
studi
medic
decisionmak
diagnost
algorithm
physician
routin
care
often
report
decis
order
viru
diagnost
often
depend
varieti
factor
level
train
media
attent
specif
request
patient
parent
typic
versu
atyp
diseas
present
avail
cost
diagnost
test
insur
statu
patient
time
constraint
etc
appli
decis
hospit
patient
safe
assum
test
rate
hospit
begin
peak
end
influenza
season
standard
diseas
sever
score
may
allow
hospit
set
object
threshold
diagnost
test
admiss
decis
depend
local
condit
epidemiolog
populationbas
indic
use
instead
individu
clinic
outcom
paramet
consider
bia
may
introduc
due
differ
patient
report
access
health
care
well
physician
awar
reimburs
creat
challeng
global
surveil
system
surveil
program
use
retrospect
chart
review
icd
code
icd
code
howev
alway
distinguish
laboratoryconfirm
case
clinic
diagnos
interperson
variabl
unpredict
natur
respiratori
viral
infect
pose
challeng
surveil
prepared
program
influenza
season
particular
vari
respect
case
number
diseas
sever
attribut
variou
viral
subtyp
popul
strata
prospect
monitor
diseas
sever
associ
laboratoryconfirm
diagnos
help
delin
vulner
subpopul
express
diseas
sever
differ
compar
popul
averag
realtim
surveil
diseas
sever
may
provid
public
health
stakehold
crucial
inform
adjust
alloc
hospit
bed
resourc
introduct
ipd
diseas
sever
assess
hospitalbas
surveil
system
facilit
time
identif
abnorm
pattern
diseas
sever
ie
though
network
analysi
time
period
overal
ili
diseas
sever
differ
previou
season
rest
year
importantli
fluctuat
diseas
sever
measur
vivi
diseas
sever
score
independ
incidencebas
surveil
indic
tradit
diseas
sever
estim
focus
extrem
present
mortal
rate
icu
admiss
design
monitor
full
spectrum
mildtosever
diseas
present
addit
granular
requir
clinic
trial
vivi
diseas
sever
score
use
follow
patient
longitudin
diseas
sever
measur
consist
time
initi
present
resolut
symptom
vivi
diseas
sever
score
also
use
measur
subtl
chang
diseas
sever
icu
patient
requir
organ
replac
therapi
standard
score
use
consist
open
path
headtohead
comparison
antivir
vaccin
prospect
ipd
metaanalys
import
investig
complex
relationship
viru
load
diseas
sever
expect
outcom
would
provid
import
clue
clinic
trial
design
patient
show
atyp
pattern
diseas
sever
exampl
neg
correl
viru
load
diseas
sever
may
repres
individu
antivir
exert
desir
effect
addit
analys
underway
understand
relationship
better
standard
diseas
sever
measur
facilit
biomark
studi
identif
viral
host
factor
associ
sever
outcom
precis
medicin
approach
would
lead
individu
risk
commun
strategi
improv
accept
vaccin
antivir
effect
low
uptak
influenza
vaccin
qm
cohort
indic
signific
number
symptomat
influenza
case
might
prevent
immun
present
work
sever
limit
current
experi
vivi
diseas
sever
score
base
singlecent
tertiari
care
set
addit
decentr
studi
need
valid
vivi
diseas
sever
score
intern
set
privat
practic
network
sever
may
lower
studi
plan
adult
elderli
includ
develop
compat
score
patientreport
outcom
possibl
differ
popul
yield
differ
result
standard
prerequisit
studi
differ
mobil
applic
particularli
use
lowresourc
set
diseas
sever
may
higher
decis
taken
instantli
final
effect
antivir
treatment
vaccin
prevent
diseas
sever
could
assess
due
minim
use
neuraminidas
inhibitor
influenza
vaccin
current
set
conclus
drawn
physician
set
hardli
ever
use
antivir
like
prescrib
antibiot
patient
appear
sever
ill
express
significantli
higher
vivi
diseas
sever
score
interest
studi
decisionmak
process
impact
differ
form
medic
intervent
diseas
sever
varieti
set
futur
point
major
sentinel
surveil
system
laboratori
base
yield
limit
clinic
inform
import
data
respect
evolut
influenza
virus
subtyp
resist
season
transmiss
would
great
benefit
monitor
diseas
sever
individu
along
region
geograph
differ
viru
circul
use
standard
diseas
sever
measur
vivi
diseas
sever
score
contribut
follow
design
hospitalbas
surveil
program
uniqu
qm
cohort
children
independ
qm
team
monitor
patient
daili
use
standard
clinic
assess
virolog
nation
refer
centr
influenza
respiratori
virus
b
novel
diseas
sever
score
vivi
diseas
sever
score
mobil
applic
detect
specif
chang
ipd
individu
cours
ill
pediatr
clinic
trial
observ
set
present
tool
line
prioriti
issu
regulatori
agenc
regard
data
standard
develop
clinic
outcom
measur
develop
new
antivir
composit
diseas
sever
score
focu
shift
virolog
clinic
end
point
impact
therapeut
intervent
qualiti
diseas
present
systemat
unbias
prospect
assess
case
whether
mild
sever
throughout
sever
season
provid
object
insight
actual
diseas
burden
influenza
respiratori
virus
mobil
health
technolog
enabl
new
precis
medicin
approach
clinic
trial
also
routin
patient
care
individu
diseas
sever
assess
children
influenza
respiratori
virus
allow
physician
commun
better
parent
patient
provid
current
statu
valid
measur
diseas
sever
compar
similar
age
popul
strata
patent
receiv
antivir
therapi
progress
measur
commun
accordingli
individu
importantli
avail
valid
diseas
sever
measur
standard
dataset
physician
abl
determin
patient
may
lag
behind
respons
therapeut
intervent
better
understand
complex
relationship
viru
load
diseas
sever
children
differ
respiratori
virus
provid
import
clue
person
approach
antivir
therapi
biomark
analys
link
standard
diseas
sever
assess
help
elucid
patient
improv
rapidli
soon
viru
load
declin
wherea
smaller
group
patient
improv
expect
latter
subgroup
patient
may
benefit
differ
therapeut
approach
exampl
immunomodul
precis
medicin
tool
vivi
diseas
sever
score
mobil
applic
provid
import
tool
object
evalu
new
antivir
soontob
treatabl
respiratori
virus
regulatori
agenc
public
health
stakehold
repeatedli
call
intern
consensu
diseas
sever
measur
influenza
respiratori
virusesthi
need
becom
immin
rapid
develop
new
antiinfect
therapi
respiratori
viral
infect
children
adultsth
challeng
data
standard
greatest
infant
young
children
may
present
subtl
atyp
symptomsbas
systemat
review
literatur
develop
composit
clinic
score
vivi
diseas
sever
score
immedi
measur
diseas
sever
acut
reparatori
infect
pointofcareth
vivi
diseas
sever
score
made
avail
webus
interfac
mobil
applic
valid
qualiti
manag
program
includ
children
year
agelink
standard
diseas
sever
score
rapid
diagnost
allow
instantan
monitor
incid
rate
acut
respiratori
viral
infect
along
sever
casewith
comprehens
manuscript
provid
insight
futur
observ
studi
clinic
trial
antivir
soontobetreat
acut
respiratori
diseas
childrenth
reader
guid
novel
analyt
approach
becom
possibl
rigor
standard
individu
patientdata
ipd
analys
diseas
sever
